SCHEMBL649860

SCHEMBL649860

C=Cc1cc(N2C[C@H]3CCN(C(=O)OC(C)(C)C)[C@H]3C2)cnc1Br

nearest known ligand 0.40

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
RET P07949 1/20 0.40
GPR119 Q8TDV5 9/20 0.36
NAMPT P43490 1/20 0.36
USP30 Q70CQ3 1/20 0.36
JAK3 P52333 2/20 0.35
SPR P35270 1/20 0.35
CCR5 P51681 2/20 0.34
CHRNB2 P17787 2/20 0.34
CHRNB4 P30926 2/20 0.34
CHRNA3 P32297 2/20 0.34
CHRNA4 P43681 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3585485 0.85 CHRNB2 (0.36) JAK3CHRNB2CHRNB4CHRNA3CHRNA4
Hydrochloric Acid SCHEMBL653100 0.84 CHRNB2 (0.49) NR1H2NR1H3RETGPR119NAMPT
SCHEMBL652866 0.84 RET (0.42) NR1H2NR1H3RETGPR119NAMPT
SCHEMBL652442 0.83 RET (0.50) NR1H2NR1H3RETGPR119NAMPT
SCHEMBL652498 0.82 RET (0.41) NR1H2NR1H3RETGPR119NAMPT
SCHEMBL649486 0.82 NR1H2 (0.44) NR1H2NR1H3RETGPR119NAMPT
SCHEMBL654453 0.81 RET (0.45) NR1H2NR1H3RETGPR119NAMPT
SCHEMBL650737 0.80 GPR119 (0.43) NR1H2NR1H3RETGPR119USP30
SCHEMBL650034 0.80 GPR119 (0.43) NR1H2NR1H3RETGPR119USP30
SCHEMBL653620 0.79 NR1H2 (0.43) NR1H2NR1H3RETGPR119NAMPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119635-B2 Diazabicyclic central nervous system active agents ABBOTT LABORATORIES (US) 2012-02-21 US disclosed
EP-2298775-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-23 EP disclosed
EP-2295437-A1 Diazabicyclic central nervous system active agents Abbott Laboratories (US) 2011-03-16 EP disclosed